Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The VIABLE Phase 3 Randomized Clinical Trial

Vogelzang, Nicholas J.; Beer, Tomasz M.; Gerritsen, Winald; Oudard, Stephane; Wiechno, Pawel; Kukielka-Budny, Bozena; Samal, Vladimir; Hajek, Jaroslav; Feyerabend, Susan; Khoo, Vincent; Stenzl, Arnulf; Csoszi, Tibor; Filipovic, Zoran; Goncalves, Frederico; Prokhorov, Alexander; Cheung, Eric; Hussain, Arif; Sousa, Nuno; Bahl, Amit; Hussain, Syed; Fricke, Harald; Kadlecova, Pavla; Scheiner, Tomas; Korolkiewicz, Roman P.; Bartunkova, Jirina; Spisek, Radek

Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The VIABLE Phase 3 Randomized Clinical Trial

Autor(en):

Vogelzang, Nicholas J.; Beer, Tomasz M.; Gerritsen, Winald; Oudard, Stephane; Wiechno, Pawel; Kukielka-Budny, Bozena; Samal, Vladimir; Hajek, Jaroslav; Feyerabend, Susan; Khoo, Vincent; Stenzl, Arnulf; Csoszi, Tibor; Filipovic, Zoran; Goncalves, Frederico; Prokhorov, Alexander; Cheung, Eric; Hussain, Arif; Sousa, Nuno; Bahl, Amit; Hussain, Syed; Fricke, Harald; Kadlecova, Pavla; Scheiner, Tomas; Korolkiewicz, Roman P.; Bartunkova, Jirina; Spisek, Radek

Tübinger Autor(en):

Stenzl, Arnulf

Erschienen in:

Jama Oncology (2022), Bd. 8, H. 4, S. 546-552

Verlagsangabe:

Amer Medical Assoc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1001/jamaoncol.2021.7298

ISSN:

2374-2437